Altered subcellular signaling in murine peritoneal macrophages upon chronic morphine exposure

Ana M Lugo-Chinchilla1, Dennise Báez, Mariella Vélez

  • 1Department of Natural Sciences, Interamerican University, Bayamón Campus, Bayamón, Puerto Rico.

Insights

Opioid exposure alters macrophage function. Acute morphine inhibits phagocytosis via a pertussis toxin-sensitive pathway, while withdrawal increases cAMP and impairs phagocytosis through a different mechanism.

Area of Science:

  • Immunology
  • Neuroscience
  • Pharmacology

Background:

  • Opioid signaling in immune cells is complex and not fully understood.
  • Macrophages play a crucial role in immune responses, including phagocytosis.
  • Opioid exposure can modulate immune cell function, impacting host defense.

Purpose of the Study:

  • To investigate the effects of acute and chronic morphine exposure on murine peritoneal macrophage function.
  • To elucidate the signaling pathways involved in morphine-induced alterations of phagocytosis and cAMP levels.
  • To understand the mechanisms underlying morphine tolerance and withdrawal in macrophages.

Main Methods:

  • Murine peritoneal macrophages were exposed to morphine acutely and chronically in vitro.
  • Fc-mediated phagocytosis assays were performed to assess macrophage function.
  • Cyclic adenosine monophosphate (cAMP) levels were measured.
  • Pertussis toxin (PT) sensitivity was evaluated to determine signaling pathways.

Main Results:

  • Acute morphine exposure inhibited Fc-mediated phagocytosis via a PT-sensitive pathway without affecting cAMP.
  • Chronic morphine exposure led to tolerance, with equivalent phagocytosis and cAMP levels.
  • Morphine withdrawal after chronic exposure inhibited phagocytosis and increased cAMP 4-fold via a PT-insensitive mechanism.
  • Elevated cAMP levels were causally linked to phagocytosis inhibition.

Conclusions:

  • Macrophage opioid receptor signaling shifts depending on the exposure conditions.
  • Acute exposure involves a Gi/o-mediated pathway not involving adenylate cyclase.
  • Chronic exposure and withdrawal involve non-Gi/o-mediated adenylate cyclase superactivation, impacting phagocytosis.